PubRank

Michael A Horberg

Author PubWeight™ 73.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009 19.90
2 Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis 2010 3.72
3 Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007 3.46
4 HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009 3.13
5 Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis 2013 2.58
6 U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 2012 2.18
7 Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med 2007 2.07
8 Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis 2009 2.05
9 HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011 2.02
10 Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clin Infect Dis 2013 1.94
11 Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med 2015 1.86
12 Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr 2013 1.72
13 Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med 2009 1.63
14 Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2014 1.51
15 Impact of age on retention in care and viral suppression. J Acquir Immune Defic Syndr 2015 1.17
16 HIV infection and incidence of ischemic stroke. AIDS 2014 1.15
17 CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther 2010 1.13
18 Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr 2014 1.13
19 Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med 2009 1.12
20 Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J Infect Dis 2011 1.11
21 The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev 2012 1.10
22 Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons. AIDS 2012 1.07
23 Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clin Infect Dis 2014 1.06
24 Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr 2016 1.05
25 Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis. J Int Assoc Provid AIDS Care 2013 1.04
26 The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction. J Acquir Immune Defic Syndr 2012 1.03
27 HMG-CoA reductase inhibitors (statins) use and risk of non-Hodgkin lymphoma in HIV-positive persons. AIDS 2011 0.98
28 Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr 2014 0.94
29 Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America. Am J Epidemiol 2015 0.90
30 Sexual dysfunction, HIV, and AIDS in men who have sex with men. AIDS Patient Care STDS 2011 0.90
31 Use of Abacavir and Risk of Cardiovascular Disease Among HIV-Infected Individuals. J Acquir Immune Defic Syndr 2016 0.89
32 Complications of herpes zoster in cancer patients. Scand J Infect Dis 2014 0.86
33 The FLU-FIT program: an effective colorectal cancer screening program for high volume flu shot clinics. Am J Manag Care 2011 0.86
34 HIV status is an independent risk factor for reporting lower urinary tract symptoms. J Urol 2011 0.85
35 Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment. J Acquir Immune Defic Syndr 2016 0.85
36 Provision of contraceptive services to women with diabetes mellitus. J Gen Intern Med 2011 0.83
37 The Patient Outcomes Research To Advance Learning (PORTAL) Network Adult Overweight and Obesity Cohort: Development and Description. JMIR Res Protoc 2016 0.79
38 Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009. PLoS One 2013 0.78
39 Increased rates of appendicitis in HIV-infected men: 1991-2005. J Acquir Immune Defic Syndr 2009 0.77
40 Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav 2015 0.77
41 Immunodeficiency, AIDS-related pneumonia, and risk of lung cancer among HIV-infected individuals. AIDS 2017 0.75
42 Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada. J Acquir Immune Defic Syndr 2017 0.75
43 Kaiser Permanente's Good Health & Great Hair Program: Partnering With Barbershops and Beauty Salons to Advance Health Equity in West Baltimore, Maryland. J Public Health Manag Pract 2022 0.75